India is importing monoclonal antibodies from Australia to treat Nipah virus infection in Kerala. The drug, m102.4, was initially developed for treating Henipavirus. Early-stage trials have shown its potential in managing NiV, which has a high mortality rate of 40-70%.
from Times of India https://ift.tt/MuI3aFV
No comments:
Post a Comment